C. Ola Landgren, M.D. (IMAGE)

University of Miami Miller School of Medicine

C. Ola Landgren, M.D.

Caption

“Today’s unanimous ODAC vote – 12-0 in favor – is a milestone for the field of multiple myeloma,” said Dr. C. Ola Landgren, director of Sylvester’s Myeloma Research Institute. “It will also set the stage for the development of novel therapies for other cancers.”

Credit

Photo by Sylvester

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.